返回 Agendas
DEVELOP Risk-Based Monitoring Strategies to INNOVATE Study Oversight and ADVANCE Study Execution
Session Chair(s)
Lynn King, MHA
Consultant
Cornerstone Clinical Research Consulting, United States
This forum will explore the lessons learned from a case study of developing and implementing a risk-based monitoring strategy for a 30-site global trial. The collaborative sponsor/contract research organization process and implications will be presented and discussed.
Learning Objective : Describe risk-based monitoring strategy for 30-site global trial; Discuss lessons learned from strategy development and implementation; Evaluate potential improvements to improve strategy development process.
Speaker(s)
Panelist
William L Tobia, MBA, MS
GlaxoSmithKline, United States
Lead Clinical Instructor
注册方法
Registration override should work.